Kistemaker Lois, van Bodegraven Emma J, de Vries Helga E, Hol Elly M
Department of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Amsterdam, The Netherlands; Amsterdam Neuroscience, Amsterdam, The Netherlands.
Trends Biotechnol. 2025 Jan 2. doi: 10.1016/j.tibtech.2024.11.021.
Human brain organoids (hBOs) are in vitro, 3D, self-organizing brain tissue structures increasingly used for modeling brain development and disease. Although they traditionally lack vasculature, recent bioengineering developments enable their vascularization, which partly recapitulates neurodevelopmental processes such as neural tube angiogenesis, formation of neurovascular unit (NVU)-like structures, and early barriergenesis. Although vascularized hBOs (vhBOs) are already used to model (defects in) neurovascular development, vascularization efficiency and other outcomes differ substantially between vascularization protocols and overall shortcomings should be considered. For instance, vessel-like structures in vhBOs do not contain blood-like flow nor do they form a functional blood-brain barrier (BBB). Extended characterization, standardization, and the development of new bioengineering techniques may enable broader applications of vhBOs such as drug transport studies.
人脑类器官(hBOs)是体外三维自组织脑组织结构,越来越多地用于模拟大脑发育和疾病。尽管传统上它们缺乏血管系统,但最近的生物工程进展使其能够实现血管化,这部分重现了神经发育过程,如神经管血管生成、神经血管单元(NVU)样结构的形成以及早期屏障形成。尽管血管化的hBOs(vhBOs)已被用于模拟神经血管发育(缺陷),但血管化效率和其他结果在不同的血管化方案之间存在很大差异,应考虑整体存在的缺点。例如,vhBOs中的类血管结构不包含类似血液的流动,也不形成功能性血脑屏障(BBB)。进一步的表征、标准化以及新生物工程技术的开发可能会使vhBOs得到更广泛的应用,如药物转运研究。